La cadena de opciones muestra datos clave de las opciones de acciones de Limoneira a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Limoneira..

Limoneira (NASDAQ:LMNR) Bolsa, Cadena de Opciones

Limoneira

Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

AVXL

BLIN

BNRG

LMNR

QCOM

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: LMNR, QCOM, AVXL, BNRG y BLIN.

5 acciones en el foco este lunes: LMNR, QCOM, AVXL, BNRG y BLIN

Limoneira Co

WIIM

Limoneira shares are trading lower after the company reported mixed Q4 financial results.

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 40 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $43.86 million which beat the analyst consensus estimate of $42.45 million by 3.32 percent. This is a 5.86 percent increase over sales of $41.43 million the same period last year.

Earnings Beats

Earnings Misses

CORRECTION: Limoneira Q4 Adj $(0.09) Misses $(0.07) Estimate, Sales $43.86M Beat $42.45M Estimate

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) announced its Q4 earnings on Monday, December 23, 2024 at 04:05 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Limoneira missed estimated earnings by -28.999999999999996%, reporting an EPS of $-0.09 versus an estimate of $-0.07.
Revenue was up $2.43 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.09 in the last quarter, resulting in a 3.0% drop share price change the following day.
Here's a look at Limoneira's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.33</td>
<td>0.19</td>
<td>-0.29</td>
<td>-0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.42</td>
<td>0.44</td>
<td>-0.18</td>
<td>-0.15</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>63.57M</td>
<td>50.55M</td>
<td>40.00M</td>
<td>37.82M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>63.30M</td>
<td>44.61M</td>
<td>39.73M</td>
<td>41.43M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Limoneira <a href="https://www.benzinga.com/quote/LMNR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Limoneira Earnings Review: Q4 Summary

Guidance

Limoneira Expects Fresh Lemon Volumes To Be In The Range Of 5M-5.5M Cartons For FY25. Avocado Volumes Are Expected To Be In The Range Of 7M-8M Pounds; Expects To Receive Total Proceeds Of $180M From Harvest, LLCB II And East Area II Spread Out Over Seven Fiscal Years, With ~$15M Received In FY24

Harvest at Limoneira Cash Flow Projections (in millions)
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Fiscal Year</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2024 Actual</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2025</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2026</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2027</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2028</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2029</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">2030</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Projected Distributions</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$15</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$8</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$18</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$34</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$41</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$22</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$42</td>
</tr>
</tbody>
</table>
</figure>
The Company has 1,000 acres of non-bearing lemons and avocados estimated to become full bearing over the next four to five years, which the Company expects will enable strong organic growth in the coming years. Additionally, the Company plans to continue expanding its plantings of avocados over the next three years and expects to have an increase in third-party grower lemons. The foregoing describes organic growth opportunities and does not include potential acquisition opportunities for the Company in its highly fragmented industry.
Looking ahead, we continue to see a strong EBITDA outlook that is underpinned by plans to expand avocado production by 1,000 acres through fiscal year 2027 to capitalize on robust consumer demand trends. During this transition, the Company expects fiscal year 2025 avocado volume to be lower compared to fiscal year 2024 due to the alternate bearing nature of avocado trees. These operational results do not take into account anticipated additional gains from asset monetization.

Limoneira Says "We Continue To See A Strong EBITDA Outlook That Is Underpinned By Plans To Expand Avocado Production By 1,000 Acres Through Fiscal Year 2027 To Capitalize On Robust Consumer Demand Trends; Expects Fiscal Year 2025 Avocado Volume To Be Lower Compared To Fiscal Year 2024 Due To The Alternate Bearing Nature Of Avocado Trees"

The CNN Money Fear and Greed index showed some easing in the fear level, with the index moving to the &#8220;Fear&#8221; zone on Friday.
U.S. stocks settled higher on Friday, with the Dow Jones index surging almost 500 points during the session.
Even as the major indices recorded gains on Friday, all three averages fell last week. The Dow dipped around 2.3% to record its third losing week in a row. The S&amp;P 500 declined about 2%, while the Nasdaq Composite fell around 1.8% last week.
On the economic data front, the U.S. personal consumption expenditures price index rose 0.1% month-over-month in November down from 0.2% in each of the prior two months and compared to market estimates of 0.2%. The University of Michigan consumer sentiment rose to 74 in December, recording the highest level since April, versus a reading of 71.8 in November.
Carnival Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) reported better-than-expected earnings for its fourth quarter on Friday.
All sectors on the S&amp;P 500 closed on a positive note, with utilities, real estate, and information technology stocks recording the biggest gains on Friday.
The Dow Jones closed higher by around 498 points to 42,840.26 on Friday. The S&amp;P 500 rose 1.09% to 5,930.85, while the Nasdaq Composite surged 1.03% to close at 19,572.60 during Friday's session.
Investors are awaiting earnings results from Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>), and Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 28.1, the index moved to the &#8220;Fear&#8221; zone on Friday, versus a prior reading of 21.9.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To 'Fear' Zone

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) to report a quarterly loss at 7 cents per share on revenue of <a href="https://www.benzinga.com/quote/LMNR/earnings">$42.45 million after</a> the closing bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Limoneira shares gained 2% to $26.83 in after-hours trading.</li>
<li>Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) bagged a key win in its legal battle against semiconductor design company Arm Holdings Plc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>). A federal jury in Delaware ruled that Qualcomm did not violate its licensing agreement with Arm, clearing a hurdle for the San Diego, California-<a href="https://www.benzinga.com/24/12/42633922/qualcomm-bags-win-in-chips-licensing-trial-against-arm-but-the-battle-is-not-over-yet">headquartered chipmaker</a>. Qualcomm shares gained 1.9% to $155.72 in the after-hours trading session.</li>
<li>Analysts expect Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) to post a quarterly loss at 16 cents per share before the opening bell. Anavex Life Sciences shares gained 0.2% to $8.65 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Brenmiller Energy Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>) shares rose sharply in after-hours trading on Friday after the company said it was awarded ISO/IEC 27001:2022 certification. Brenmiller Energy shares surged 12% to $0.8440 in the after-hours trading session.</li>
<li>Analysts expect Bridgeline Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) to post a quarterly loss at 5 cents per share on revenue of $3.87 million after the closing bell. Bridgeline Digital shares fell 0.7% to $1.48 in after-hours trading.</li>
</ul>
Check This Out:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></li>
</ul>
Photo courtesy: Shutterstock

Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday

<h3>Companies Reporting Before The Bell</h3>
• Anavex Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) is expected to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $3.87 million. 
• Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) is expected to report quarterly loss at $0.07 per share on revenue of $42.45 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Scheduled For December 23, 2024

Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) has significantly <a href="https://www.benzinga.com/markets/equities/23/12/36046659/why-citrus-fruits-company-limoneiras-shares-are-seeing-blue-skies-today">raised its expectations</a> on avocado volumes this year to take advantage of higher prices for the fruit.
&#8220;We now expect avocado volumes to be in the range of 14.5 million to 15.5 million pounds for fiscal year 2024 compared to previous guidance of 9 million to 10 million pounds, a more than 50% increase compared to prior guidance,&#8221; CEO Harold Edwards said on Monday during a third-quarter earnings call with analysts.
&#8220;We expect to complete the avocado harvest in the fourth quarter with approximately 4 million to 5 million pounds remaining. Keep in mind, we expect our fourth quarter to represent a record in avocado volume due to our timing and ability to hold the fruit to match a higher pricing environment.&#8221;
The company recorded $13.9 million&nbsp;of avocado revenue in the third quarter of fiscal year 2024, compared to&nbsp;$3.5 million&nbsp;in the third quarter of last fiscal year. 
Read Also: <a href="https://www.benzinga.com/general/24/05/39029025/avocado-toast-isnt-the-problem-gen-z-faces-maximum-credit-card-debt-and-lower-earnings-compared-to-a">Avocado Toast Isn&#8217;t The Problem: Gen Z Faces Maximum Credit Card Debt And Lower Earnings Compared To Any Other Generation, Finds The Fed</a>
About 8.86 million pounds of avocados were sold in aggregate during the third quarter of fiscal year 2024 at a&nbsp;$1.57&nbsp;average price per pound, compared to approximately 2.82 million pounds sold at a&nbsp;$0.99&nbsp;average price per pound during the third quarter of fiscal year 2023.
Limoneira posted $63.3 million in net revenue for this year&#8217;s third quarter, up from $52.5 million a year ago.
Limoneira expects to expand avocado production by 1,000 acres over the next three years to take advantage of robust consumer demand but expects volume to be lower next year as a result of the yearly alternate bearing nature of avocado trees, CFO Mark Palamountain said.
The company expects avocado pricing to be lower in 2025 despite forecasting lower volume that year, he said.
&#8220;The company believes avocado pricing may be slightly lower compared to the current year pricing environment due to international circumstances,&#8221; he said.
Price Action: Shares of Limoneira were down 3.2% to $24.20 at the time of publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/real-estate/24/06/39182926/dont-blame-the-avocado-toast-millennials-and-gen-z-getting-better-mortgage-rates">Don&#8217;t Blame The Avocado Toast: Millennials And Gen Z Getting Better Mortgage Rates</a></li>
</ul>
Photo: OlgaBombologna/Shutterstock.com

Why Avocado Toast May Get A Lot Cheaper

Lake Street analyst Ben Klieve downgrades Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) from Buy to Hold and maintains the price target from $25 to $25.

Downgrades

Price Target

Analyst Ratings

Lake Street Downgrades Limoneira to Hold, Maintains Price Target to $25

The Company now expects avocado volumes to be in the range of 14.5 million to 15.5 million pounds for fiscal year 2024, compared to previous&nbsp;guidance&nbsp;of 9.0 million to 10.0 million pounds, a more than&nbsp;50%&nbsp;increase compared to prior&nbsp;guidance.&nbsp;
The Company now expects fresh lemon volumes to be in the range of 4.5 million to 5.0 million cartons for fiscal year 2024, compared to previous&nbsp;guidance&nbsp;of 5.0 million to 5.5 million cartons, due to lower fresh utilization from late season rains. The lemon harvest for fiscal year 2024 is approximately&nbsp;85%&nbsp;complete.

Limoneira Boosts Avocado Volume Guidance For FY24; Expects FY25 Avocado Volume To Be Lower Y/Y Due To The Alternate Bearing Nature Of Avocado Trees

Limoneira Says Strategic Alternatives Exploration To Maximize Stockholder Value Continues To Progress

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.34 by 23.53 percent. This is a 2000 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $63.30 million which missed the analyst consensus estimate of $63.57 million by 0.41 percent. This is a 20.59 percent increase over sales of $52.50 million the same period last year.

Limoneira Q3 2024 Adj EPS $0.42 Beats $0.34 Estimate, Sales $63.30M Miss $63.57M Estimate

B. Riley Securities maintains Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) with a Buy and raises the price target from $24 to $28.

B. Riley Securities Maintains Buy on Limoneira, Raises Price Target to $28

Limoneira shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its guidance. Also, Lake Street maintained a Buy rating on the stock and raised its price target from $23 to $25.

Looking ahead, the Company is raising its outlook for non-GAAP EBITDA accretion to a range of $45 million to $55 million by fiscal year 2030, up from its previous target of $30 million. This increase is underpinned by plans to significantly expand avocado production by 1,000 acres over the next three years to capitalize on robust consumer demand trends. During this transition, the Company expects FY 2025 and FY 2026 operational results to be similar to FY 2024. These operational results do not take into account expected additional earnings from Harvest at Limoneira.

Limoneira Said It Is Raising Its Outlook For Non-GAAP EBITDA Accretion To A Range Of $45M-$55M By Fiscal Year 2030, Up From Its Previous Target Of $30M

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.18 by 144.44 percent. The company reported quarterly sales of $44.606 million which missed the analyst consensus estimate of $53.963 million by 17.34 percent. This is a 7.21 percent decrease over sales of $48.070 million the same period last year.

Thursday June 6, 2024 Limoneira Reported Q2 Adj EPS $0.44 Beats $0.18 Estimate, Sales $44.606M Miss $53.963M Estimate

Lake Street analyst Ben Klieve maintains Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) with a Buy and raises the price target from $23 to $25.

Lake Street Maintains Buy on Limoneira, Raises Price Target to $25

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday.
Shares of Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/AGX/earnings">first-quarter financial results</a>.
Argan posted quarterly earnings of 58 cents per share, beating market estimates of 52 cents per share. The company's quarterly sales came in at $157.68 million versus expectations of $134.75 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Argan shares climbed 11.1% to $76.78 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) shares climbed 26% to $4.90 as the company reported the FDA approval of RYTELO&#x2122; (imetelstat), a first-in-class telomerase inhibitor, for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares jumped 18.8% to $4.11.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) rose 18.3% to $43.49 after the company approved a share buyback and raised its Q2 guidance.</li>
<li>Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) climbed 14.7% to $5.42. Yext is said to hire investment bankers to explore strategic alternatives, including a sale, Reuters reported.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) climbed 9.6% to $1.9950 following better-than-expected quarterly earnings.</li>
<li>Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) gained 9.4% to $22.27 as the company reported financial results for the second quarter ended April 30, 2024.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) gained 8.7% to $2.6850.</li>
<li>Waldencast plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WALD#NASDAQ">WALD</a>) rose 8.6% to $4.77.</li>
<li>NWTN Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) climbed 8.5% to $2.17.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) gained 7.8% to $39.57. B. Riley Securities analyst Hal Goetsch initiated coverage on Dave with a Buy rating and announced a price target of $60.</li>
<li>Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) rose 7.6% to $29.48.</li>
<li>Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) gained 7.2% to $27.72.</li>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) gained 4.2% to $38.32 following better-than-expected first-quarter earnings.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 3.7% to $108.49.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39227364/this-exxon-mobil-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday">This Exxon Mobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday</a>

Intraday Update

Movers

BRZE

CRDO

CVNA

DAVE

ESPR

GERN

MBLY

NWTN

SPWR

WALD

YEXT

Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday

Hormel Foods (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrl#NYSE">HRL</a>) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.40 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 8.57%. A quarter ago, it was expected that this maker of Spam canned ham, Dinty Moore stew and other foods would post earnings of $0.34 per share when it actually produced earnings of $0.41, delivering a surprise of 20.59%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Hormel, which belongs to the Zacks Food - Meat Products industry, posted revenues of $2.89 billion for the quarter ended April 2024, missing the Zacks Consensus Estimate by 3.35%. This compares to year-ago revenues of $2.98 billion. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Hormel shares have added about 6.2% since the beginning of the year versus the S&amp;P 500&#39;s gain of 10.4%.
What&#39;s Next for Hormel?
While Hormel has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Hormel: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.38 on $3.01 billion in revenues for the coming quarter and $1.59 on $12.26 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Food - Meat Products is currently in the top 22% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Limoneira (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmnr#NASDAQ">LMNR</a>), another stock in the broader Zacks Consumer Staples sector, has yet to report results for the quarter ended April 2024. The results are expected to be released on June 6.
This agribusiness company is expected to post quarterly earnings of $0.21 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Limoneira&#39;s revenues are expected to be $54.62 million, up 13.6% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2281110/hormel-foods-hrl-q2-earnings-beat-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2281110">To read this article on Zacks.com click here.</a>

Small Cap

Hormel Foods Q2 Earnings Beat Estimates

Limoneira Company declares $0.075 dividend

Fresh Del Monte: Under The Radar, Long-Term Dividend Investors May Love This One

Catalyst Watch: Labor pains for Amazon & Starbucks, Nasdaq call-up for MicroStrategy and Pony AI ratings

In a report released today, Ben Klieve from Lake Street assigned a Hold rating to Limoneira Co (LMNR – Research Report), with a price target of $25...

Lake Street Releases a Hold Rating on Limoneira Co (LMNR)

Limoneira Company Non-GAAP EPS of -$0.09 misses by $0.02, revenue of $43.86M beats by $1.41M

"Looking ahead, we continue to see a strong EBITDA outlook that is underpinned by plans to expand avocado production by 1,000 acres through fiscal ...

Limoneira sees FY25 avocado volume lower compared to FY24

The Company expects fresh lemon volumes to be in the range of 5M to 5.5M cartons for fiscal year 2025. Avocado volumes are expected to be in the ra...

Limoneira sees FY25  fresh lemon volumes  5M-5.5M cartons

Reports Q4 revenue $43.9M, consensus $42.45M.Harold Edwards, President and Chief Executive Officer of the Company, stated, "Our achievement of soli...

Limoneira reports Q4 EPS (9c), consensus (7c)

In October 2023, the Company's joint venture closed on lot sales representing 121 residential units, thus completing the sell-out of Phase 1 of the...

Limoneira says completed sell-out of Phase 1 of development of JV

ALMS

AMTM

AMZN

AXON

CRVL

CVLG

DXST

GALT

GLATF

GOEV

ILMN

KELYA

MRNA

MSTR

NDSN

NMRA

NUKK

PLTR

PONY

QMCO

QRVO

QUBT

RYTM

SAVA

SBUX

SLNO

SMCI

WBTN

WDAY

Press Releases

Limoneira to Announce Second Quarter 2024 Financial Results on June 6, 2024

Limoneira Company Announces Second Quarter Fiscal Year 2024 Financial Results

Limoneira Declares Quarterly Dividend

Limoneira to Announce Third Quarter 2024 Financial Results on September 9, 2024

Limoneira Company Announces Third Quarter Fiscal Year 2024 Financial Results

Limoneira to Participate in Fireside Chat at Stephens Annual Investment Conference

Limoneira to Announce Fourth Quarter and Full Fiscal Year 2024 Financial Results on December 23, 2024

Limoneira Company Announces Fiscal Fourth Quarter and Full Year 2024 Financial Results

Archer-Daniels-Midland Company Common Stock

Archer-Daniels Midland

AgriFORCE Growing Systems Ltd. - Common Shares

AgriFORCE Growing Systems

Alico

Bunge Global

Benson Hill

Cresud S.A.C.I.F. y A. - American Depositary Shares, each representing ten shares of Common Stock

Comments

Limoneira

Limoneira (LMNR) Opciones

Limoneira (NASDAQ:LMNR) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL